IS7012A - Adenósín A2A viðtaka gerandefni og and-kólínergurmiðill í blöndu til meðhöndlunar á teppandi kokrennusjúkdómum - Google Patents

Adenósín A2A viðtaka gerandefni og and-kólínergurmiðill í blöndu til meðhöndlunar á teppandi kokrennusjúkdómum

Info

Publication number
IS7012A
IS7012A IS7012A IS7012A IS7012A IS 7012 A IS7012 A IS 7012A IS 7012 A IS7012 A IS 7012A IS 7012 A IS7012 A IS 7012A IS 7012 A IS7012 A IS 7012A
Authority
IS
Iceland
Prior art keywords
cocaine
obstructive
adenosine
disease
mixture
Prior art date
Application number
IS7012A
Other languages
English (en)
Inventor
A. Armstrong Roisin
Yeadon Michael
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0129275A external-priority patent/GB0129275D0/en
Priority claimed from GB0129396A external-priority patent/GB0129396D0/en
Priority claimed from GB0210240A external-priority patent/GB0210240D0/en
Priority claimed from GB0210238A external-priority patent/GB0210238D0/en
Priority claimed from PCT/EP2002/005725 external-priority patent/WO2002096462A1/en
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of IS7012A publication Critical patent/IS7012A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
IS7012A 2001-05-25 2003-10-31 Adenósín A2A viðtaka gerandefni og and-kólínergurmiðill í blöndu til meðhöndlunar á teppandi kokrennusjúkdómum IS7012A (is)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US29384201P 2001-05-25 2001-05-25
US29360601P 2001-05-25 2001-05-25
GB0129275A GB0129275D0 (en) 2001-12-06 2001-12-06 Pharmaceutical combination
GB0129396A GB0129396D0 (en) 2001-12-07 2001-12-07 Pharmaceutical combination
GB0210240A GB0210240D0 (en) 2002-05-03 2002-05-03 Pharmaceutical combination
GB0210238A GB0210238D0 (en) 2002-05-03 2002-05-03 Pharmaceutical composition
PCT/EP2002/005725 WO2002096462A1 (en) 2001-05-25 2002-05-24 An adenosine a2a receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases

Publications (1)

Publication Number Publication Date
IS7012A true IS7012A (is) 2003-10-31

Family

ID=37667302

Family Applications (2)

Application Number Title Priority Date Filing Date
IS7015A IS7015A (is) 2001-05-25 2003-10-31 PDE 4 hindri og and-kólínergur miðill í blöndu til meðhöndlunar á teppandi kokrennusjúkdómum
IS7012A IS7012A (is) 2001-05-25 2003-10-31 Adenósín A2A viðtaka gerandefni og and-kólínergurmiðill í blöndu til meðhöndlunar á teppandi kokrennusjúkdómum

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IS7015A IS7015A (is) 2001-05-25 2003-10-31 PDE 4 hindri og and-kólínergur miðill í blöndu til meðhöndlunar á teppandi kokrennusjúkdómum

Country Status (1)

Country Link
IS (2) IS7015A (is)

Also Published As

Publication number Publication date
IS7015A (is) 2003-10-31

Similar Documents

Publication Publication Date Title
EE200300586A (et) Adenosiini A2A retseptori agonisti ja antikolinergilise vahendi kombinatsioon obstruktiivsete hingamisteede haiguste raviks
NO20032277D0 (no) Aminotiazoler og deres anvendelse som adenosinreseptorantagonister
IS7801A (is) Púrín efnasambönd og notkun þeirra sem kannabinóíð viðtaka bindla
TWI349550B (en) A thiazole derivative and adenosine a2a receptor antagonist containing the same
EP1583503A4 (en) POLYVALENT LYMPHOTOXIN BETA RECEPTOR AGONISTS AND THERAPEUTIC USE THEREOF
NO20011625L (no) Skummede brönnsementsammensetninger med höy styrke og fremgangsmåter
AU2003273300A1 (en) Modified glp-1 receptor agonists and their pharmacological methods of use
DE60110219D1 (de) Adenosin a2a rezeptor antagonisten
DE60234951D1 (de) Adenosin a2a rezeptor antagonisten
IL209010A0 (en) Use of tnfalpha antibodies and another drug
IL160706A0 (en) Peptides acting as both glp-1 receptor agonists and their pharmacological methods of use
IL161572A0 (en) Adenosine a2a receptor antagonists
IL163743A0 (en) Haloacetamide and azide substituted compounds and methods of use thereof
IL178254A0 (en) Receptor coupling agents and therapeutic uses thereof
HUP0401987A3 (en) Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments
GB0107822D0 (en) Sapogenin derivatives their synthesis and use methods based upon their use
AU2002351175A8 (en) Novel human g-protein coupled receptor, hgprbmy31, and variants and methods of use thereof
NO20043295L (no) Faste salt-benzazepinforbindelser og deres anvendelse ved fremstilling av farmasoytiske forbindelser
IS7012A (is) Adenósín A2A viðtaka gerandefni og and-kólínergurmiðill í blöndu til meðhöndlunar á teppandi kokrennusjúkdómum
NO20033120L (no) 2-arylimino-2,3-dihydrotiazolderivater, fremgangsmåter for fremstilling derav og terapeutisk anvendelse derav
NO20030547L (no) Azabicykliske derivater og deres terapeutiske anvendelse
NO20042810L (no) Venflaxine-hydroklorid-monohydrat og fremgangsmater for fremstilling derav
HUP0402540A3 (en) Pharmaceutical combinations of adenosine a-2a and betha-2-adrenergic receptor agonists
NO20042500L (no) Chemokin-reseptorantagonister og metoder for anvendelse derav
IS2487B (is) Asýloxýpýrrólidín afleiður, framleiðsla og meðferðarnotkun þar á